Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Applied Nanoscience Issues Progress Report

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today issued the following progress report:

Applied Nanoscience Issues Progress Report

CARLSBAD, CA | Posted on March 6th, 2008

Testing of filter samples incorporating the company's proprietary silver nanoparticle formulation were tested after a simulated one-year aging process and proved to be highly effective in eradicating avian influenza. An independent BSL-3 laboratory reported a 3.6 log reduction (equivalent to a 99.96% reduction) in the avian influenza simulant H9N2 when exposed to the one-year aged nanoparticle enhanced filter media.

The technology, which has been under development for the past several years, has demonstrated effectiveness against a broad range of other pathogens, such as Staphylococcus aureus, Streptococcus pneumoniae, and the drug resistant S. aureus MRSA.

"We are very encouraged at the sustained progress made with our Nanoparticle - Enhanced - Filtration - Technology platform. The continued focus of our scientific team to include recent scale-up success has put us in a position to begin targeting license partners in a number of consumer markets," said Thomas Allen, President and CEO, ANI.

On February 8, 2008 Applied Nanoscience filed a Form 10-SB under Section 12(g) of The Securities Exchange Act of 1934 to become a fully reporting company. Filing this document one of the necessary steps the company must take to advance to the OTC Bulletin Board (OTCBB). An eventual listing on the OTCBB is expected to enhance the company's profile in public equity markets and make it easier to attract financing.

####

About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration products, systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.

For more information, please click here

Contacts:
Philippe Niemetz
PAN Consultants Ltd.
800-477-7570
or
212-344-6464

Investor Relations

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers engineer improvements of technology used in digital memory November 24th, 2014

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Cooling with the coldest matter in the world November 24th, 2014

Investments/IPO's/Splits

Nanometrics Announces Upcoming Investor Events November 19th, 2014

Eight19 secures 1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Arrowhead to Present at Upcoming Conferences November 15th, 2014

Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014

Announcements

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Cooling with the coldest matter in the world November 24th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE